The particle size does not exceed 200 nanometers, which ensures the stability of the composition and extends the shelf life up to six months. To create nanoparticles, ultraviolet radiation is used, which forms bonds between protein molecules without the use of toxic chemicals.
Serum albumin, the main protein in the blood, naturally binds drugs and increases their solubility. The new development preserves these properties while also protecting the active ingredients from destruction and preventing them from being lost during transportation.
The toxicity of the resulting suspension does not exceed 10%, making it suitable for biomedical use. The technology can be used in targeted therapy for cancer, enabling precise delivery of drugs to affected tissues.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
